切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2021, Vol. 08 ›› Issue (01) : 33 -36. doi: 10.3877/cma.j.issn.2095-7157.2021.01.006

所属专题: 文献

综述

门脉高压性小肠病
宋丹丹1, 柴宁莉1,()   
  1. 1. 100853 北京,解放军总医院第一医学中心消化内科
  • 收稿日期:2020-04-15 出版日期:2021-02-15
  • 通信作者: 柴宁莉

Portal hypertensive enteropathy

Dandan Song1, Ningli Chai1,()   

  1. 1. Department of Gastroenterology & Hepatology, First Medical Center of the Chinese PLA General Hospital, Beijing 100853, China
  • Received:2020-04-15 Published:2021-02-15
  • Corresponding author: Ningli Chai
引用本文:

宋丹丹, 柴宁莉. 门脉高压性小肠病[J]. 中华胃肠内镜电子杂志, 2021, 08(01): 33-36.

Dandan Song, Ningli Chai. Portal hypertensive enteropathy[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(01): 33-36.

小肠改变是门脉高压门静脉高压症是一组由门静脉压力持续增高引起的症候群,最常见表现是消化道出血,特别是食管胃静脉曲张破裂出血。随着小肠检查手段的发展,特别是胶囊内镜和双气囊小肠镜,发现门脉高压下小肠发生了病变,被定义为门脉高压性小肠病(PHE),这种改变也是消化道出血的重要原因。消化道出血的患者,胃或食管没有静脉曲张情况下不应忽略PHE的排查。

Portal hypertension is a group of symptoms caused by the continuous increase of portal pressure. The most common manifestation is gastrointestinal bleeding, especially esophageal and gastric varices bleeding. With the development of small intestine examination, especially capsule endoscopy and double balloon enteroscopy, the portal hypertension features in the small intestine was defined as portal hypertension enterophy(PHE), which could be a source of gastrointestinal bleeding. Therefore, in patients with gastrointestinal bleeding, the examination of PHE should not be ignored when there is no varicose vein in the stomach or esophagus.

[1]
Thiruvengadam R, Gostout CJ.Congestive gastroenteropathy-an extension of nonvariceal upper gastrointestinal bleeding in portal hypertension[J]. Gastrointest Endosc, 1989, 35(4): 504-507.
[2]
De Palma GD, Rega M, Masone S, et al.Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study[J]. Gastrointest Endosc, 2005, 62(4): 529-534.
[3]
Aoyama T, Oka S, Aikata H, et al.Small bowel abnormalities in patients with compensated liver cirrhosis[J]. Dig Dis Sci, 2013, 58(5): 1390-1396.
[4]
Higaki N, Matsui H, Imaoka H, et al.Characteristic endoscopic features of portal hypertensive enteropathy[J]. J Gastroenterol, 2008, 43(5): 327-331.
[5]
Kodama M, Uto H, Numata M, et al.Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy[J]. J Gastroenterol, 2008, 43(8): 589-596.
[6]
Abdelaal UM, Morita E, Nouda S, et al.Evaluation of portal hypertensive enteropathy by scoring with capsule endoscopy: is transient elastography of clinical impact?[J]. J Clin Biochem Nutr, 2010, 47(1): 37-44.
[7]
Huang WH, Hsu C, Chao YC.Colonic polypoid lesions: an unusual endoscopic presentation of portal hypertensive colonopathy[J]. Gastrointest Endosc, 1999, 50(2): 283-285.
[8]
Zeitoun JD, Chryssostalis A, Terris B, et al.Portal hypertensive duodenal polyp- A case report[J]. World J Gastroenterol, 2007, 13(9): 1451-1452.
[9]
Devadason D, Murphy MS, Brown R, et al.Duodenal capillary hemangiomatous polyps: a novel manifestation of extrahepatic portal hypertension?[J]. J Pediatr Gastroenterol Nutr, 2007, 45(1): 114-116.
[10]
Tang SJ, Jensen D, Gralnek IF, et al.Portal hypertensive enteropathy in a patient with polycystic liver disease: a unique endoscopic finding[J]. Gastrointest Endosc, 2002, 56(6): 924-926.
[11]
Sawada K, Ohtake T, Ueno N, et al.Multiple portal hypertensive polyps of the jejunum accompanied by anemia of unknown origin[J]. Gastrointest Endosc, 2011, 73(1): 179-182.
[12]
Tang SJ.Portal hypertensive polypoid enteropathy[J]. Gastrointest Endosc, 2011, 73(6): 1332.
[13]
Laskaratos FM, Toumpanakis C, Clark I, et al.Diagnosis of polypoid portal hypertensive enteropathy due to superior mesenteric vein thrombosis by capsule endoscopy and double-balloon enteroscopy[J]. Endoscopy, 2014, 46(Suppl 1): E592-E593.
[14]
Jeon SR, Kim JO.Capsule Endoscopy for Portal Hypertensive Enteropathy[J]. Gastroenterol Res Pract, 2016, 2016: 8501394.
[15]
Al-Azzawi Y, Spaho L, Mahmoud M, et al.Video Capsule Endoscopy in the Assessment of Portal Hypertensive Enteropathy[J]. Int J Hepatol, 2018, 2018: 5109689-5109689.
[16]
Mekaroonkamol P, Cohen R, Chawla S. Portal hypertensive enteropathy[J]. World J Hepatol, 2015, 7(2): 127-138.
[17]
Rondonotti E, Villa F, Signorelli C, et al.Portal Hypertensive Enteropathy[J]. Gastrointest Endosc Clin N Am, 2006, 16(2): 277-286.
[18]
Jeon SR, Kim JO, Kim JB, et al.Portal hypertensive enteropathy diagnosed by capsule endoscopy in cirrhotic patients: a nationwide multicenter study[J]. Dig Dis Sci, 2014, 59(5): 1036-1041.
[19]
Akyuz F, Pinarbasi B, Ermis F, et al.Is portal hypertensive enteropathy an important additional cause of blood loss in portal hypertensive patients?[J]. Scand J Gastroenterol, 2010, 45(12): 1497-1502.
[20]
Figueiredo P, Almeida N, Lerias C, et al.Effect of portal hypertension in the small bowel: an endoscopic approach[J]. Dig Dis Sci, 2008, 53(8): 2144-2150.
[21]
Canlas KR, Dobozi BM, Lin S, et al.Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia[J]. J Clin Gastroenterol, 2008, 42(7): 844-848.
[22]
Kodama M, Uto H, Numata M, et al.Endoscopic characterization of the small bowel in patients with portal hypertension evaluated by double balloon endoscopy[J]. J Gastroenterol, 2008, 43(5): 589-596.
[23]
Goulas S, Triantafyllidou K, Karagiannis S, et al.Capsule endoscopy in the investigation of patients with portal hypertension and anemia[J]. Can J Gastroenterol, 2008, 22(5): 469-474.
[24]
Misra SP, Dwivedi M, Misra V, et al.Ileal varices and portal hypertensive ileopathy in patients with cirrhosis and portal hypertension[J]. Gastrointest Endosc, 2004, 60(5): 778-783.
[25]
Alessandro R, Marco P, Antonio O, et al.Capsule Endoscopy in Cirrhotic Patients: Prevalence and Spectrum of Small Bowel Lesions[J]. Gastrointest Endosc, 2005, 61(5): AB158.
[26]
Kunihara S, Oka S, Tanaka S, et al. Predictive Factors of Portal Hypertensive Enteropathy Exacerbation in Patients with Liver Cirrhosis: A Capsule Endoscopy Study[J]. Digestion, 2018, 98(1): 33-40.
[27]
Aoyama T, Oka S, Aikata H, et al.Major predictors of portal hypertensive enteropathy in patients with liver cirrhosis[J]. J Gastroenterol Hepatol, 2015, 30(1): 124-130.
[28]
Zwiebel WJ, Mountford RA, Halliwell MJ, et al.Splanchnic blood flow in patients with cirrhosis and portal hypertension: investigation with duplex Doppler US[J]. Radiology, 1995, 194(3): 802-812.
[29]
Nagral AS, Joshi AS, Bhatia SJ, et al.Congestive jejunopathy in portal hypertension[J]. Gut, 1993, 34(5): 694-697.
[30]
Aller MA, Arias JL, Cruz A, et al.Inflammation: a way to understanding the evolution of portal hypertension[J]. Theor Biol Med Model, 2007, 4(1): 44-69.
[31]
Galli S, Kalesnikoff J, Grimbaldeston M, et al.Mast cells as "tunable" effector and immunoregulatory cells: Recent advances[J]. Ann Rev Immunol, 2005, 23: 749-786.
[32]
Abraldes JG, Iwakiri Y, Loureiro-Silva M, et al.Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state[J]. Am J Physiol Gastrointest Liver Physiol, 2006, 290(5): G980-G987.
[33]
Fernandez M, Mejias M, Garcia-Pras E, et al.Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats[J]. Hepatology, 2007, 46(4): 1208-1217.
[34]
Lopez-Talavera JC, Cadelina G, Olchowski J, et al.Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats[J]. Hepatology, 1996, 23(6): 1616-1621.
[35]
Jimenez-Saenz M, Romero-Vazquez J, Romero-Vazquez J, et al.Beneficial effects and reversion of vascular lesions by thalidomide in a patient with bleeding portal hypertensive enteropathy[J]. Dig Liver Dis, 2010, 42(3): 232-233.
[1] 李佳丽, 吴杨, 张莉, 夏斌, 何洋, 陈忠, 唐军, 母得志. 新生儿消化道穿孔患儿的临床特点及治疗结局[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(06): 703-711.
[2] 张非红, 夏斌. 肠道菌群失调与新生儿坏死性小肠结肠炎发病机制的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 523-527.
[3] 杜明华, 郭润, 张文华, 胡森. 电针足三里穴对肠缺血再灌注损伤大鼠小肠黏膜上皮紧密连接蛋白ZO-1的调节作用[J]. 中华损伤与修复杂志(电子版), 2022, 17(04): 315-321.
[4] 李小龙, 彭飞, 邢虹, 张朋飞, 徐泉, 赵静儒, 李占魁, 郭金珍, 白瑞苗. 局部脑氧饱和度和肠道血氧饱和度对新生儿坏死性小肠结肠炎早期预警及手术治疗时机的指导价值[J]. 中华普通外科学文献(电子版), 2023, 17(01): 45-49,68.
[5] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[6] 周铖, 袁野, 张鹏, 蔡明, 陈俊华, 尹玉平, 李伟, 向帆, 李钢, 陶凯雄, 王征, 王国斌. 小肠移植新时期:成就与挑战并存[J]. 中华普外科手术学杂志(电子版), 2022, 16(06): 703-706.
[7] 王博, 郭利君, 李二强, 张贺林, 徐鹏, 杨晓春. 消化道与口腔黏膜组织在输尿管重建中的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 434-439.
[8] 田浩, 关旭, 李进, 徐正, 刘骞, 刘正, 裴炜, 梁建伟, 王锡山, 周海涛. 腹部无辅助切口经自然腔道取出标本的完全腹腔镜小肠间质瘤切除术四例近期疗效分析[J]. 中华结直肠疾病电子杂志, 2022, 11(06): 511-515.
[9] 杨忠华, 马晓菡, 刁磊, 胡静, 陈熙. 双气囊小肠镜在小肠CT造影结果阴性患者中的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 475-479.
[10] 姜里蛟, 张峰, 周玉萍. 多学科诊疗模式救治老年急性非静脉曲张性上消化道大出血患者的临床观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 520-524.
[11] 朱风尚, 舍玲, 丁永年, 杨长青. 警惕炎症性肠病与少见肠道疾病的鉴别诊断[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 273-276.
[12] 郭亮亮, 邱珊珊, 钟萍, 赵心恺. 血小板-白蛋白-胆红素评分对肝硬化上消化道出血的诊断价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 216-219.
[13] 周嫏嬛, 龚伟玲, 孙孚春, 宋颂. 生长抑素联合乌司他丁治疗消化道出血的Meta分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(01): 26-32.
[14] 张修礼, 郭敬翰. 强化消化内镜医师对Cameron病变的认识[J]. 中华消化病与影像杂志(电子版), 2022, 12(05): 257-259.
[15] 邱春华, 张志宏. 1108例小肠疾病的临床诊断及检查策略分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 948-954.
阅读次数
全文


摘要